attributes |
DNA extraction batch |
batch3 |
ENA first public |
2017-08-16 |
ENA last update |
2016-10-21 |
ENA-CHECKLIST |
ERC000017 |
External Id |
SAMEA3920588 |
INSDC center alias |
UH/IB |
INSDC center name |
Institute of Biotechnology, University of Helsinki |
INSDC first public |
2017-08-16T17:01:50Z |
INSDC last update |
2016-10-21T09:38:38Z |
INSDC status |
public |
Submitter Id |
a105 |
acne medication |
isotretinoin |
acne severity back |
0 |
acne severity face |
6 |
collection date |
2012-09-11 |
dermatology disorder |
acne |
environment (biome) |
human-associated habitat |
environment (feature) |
skin |
environment (material) |
skin |
geographic location (country and/or sea) |
Finland |
geographic location (latitude) |
65.0090556 |
geographic location (longitude) |
25.5180278 |
host age |
15 |
host body site |
back |
host disease status |
no |
host sex |
female |
host subject id |
43R |
human skin environmental package |
human-skin |
investigation type |
metagenome |
pcr primers |
forward: AGAGTTTGATCMTGGCTCAG, reverse: GTATTACCGCGGCTGCTG |
project name |
Acne microbiome and medication |
sample collection device or method |
swab |
sample name |
a105 |
sampletype |
after_treatment |
sequencing method |
Illumina MiSeq |
sequencing run |
run2 |
target gene |
16S |
target subfragment |
V1-V3 |
|